Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virus

European Journal of Pediatrics

Volumn 158, Issue 3, 1999, Pages 187-199

  Muller F M C ^a,b   Groll, A H ^b   Walsh, T J ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antifungals; Dimorphic fungi; Molecular diagnosis; Mucosal and invasive fungal infections; Yeasts and filamentous fungi

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ATOVAQUONE; CLOTRIMAZOLE; COTRIMOXAZOLE; DAPSONE; FLUCONAZOLE; FOLINIC ACID; FUNGUS VACCINE; ITRACONAZOLE; MICONAZOLE; NYSTATIN; PENTAMIDINE; PREDNISONE; PYRROLE DERIVATIVE; RECOMBINANT CYTOKINE;

CANDIDA ALBICANS; COCCIDIOIDES IMMITIS; COMORBIDITY; CRYPTOCOCCUS NEOFORMANS; DOSE RESPONSE; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; HUMANS; MYCOSES;

EID: 0033068009     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051047     Document Type: Review

References (111)

1. 1. Aly R, Berger T (1996) Common superficial fungal infections in patients with AIDS. Clin Infect Dis 22 [Suppl 2]:128-132
2. 2. American Academy of Pediatrics (1997) Antimicrobials and related therapy. In: Peter G (ed) Red book: report of the committee on infectious diseases. 24th edn. American Academy of Pediatrics, Elk Grove Village, IU. pp 627-631
3. 3. American Thoracic Society (1995) Fungal infection in HIV-infected persons. Am J Respir Crit Care Med 152:816-822
4. 4. Bernstein LJ, Bye MR, Rubinstein A (1989) Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am J Dis Child 143:775-778
5. 5. Berry AJ, Kerkering TM, Giordano AM, Chiancone J (1984) Phaeohyphomycoti sinusitis. Pediatr Infect Dis 3:150-152
6. 6. Bonacini M, Young T, Laine L (1991) The causes of esophageal symptoms in human immunodeficiency virus infection: a prospective study of 110 patients. Arch Int Med 151:1567-1572
7. 7. Bottone E, Wormser G (1985) Capsule-deficient cryptococci in AIDS. Lancet 2:553
8. 8. Bozzette SA, Larsen RA, Chiu J, et al (1991) A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 324:580
9. 9. Braegger CP, Albisetti M, Nadal D (1995) Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS. J Pediatr Gastroenterol Nutr 21:104-106
10. 10. Byers M, Feldman S, Edwards J (1992) Disseminated histoplasmosis as the acquired immunodeficiency syndrome-defining illness in an infant. Pediatr Infect Dis J 11:127-128
11. 11. Catanzaro A, Galgiani JN, Levine BE, Sharkey-Mathis PK, Fierer J, Stevens DA, Chapman SW, Cloud G (1995) Fluconazole in the treatment of chronic pulmonary and non-meningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med 98:249-256
12. 12. CDC (1995) Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 44, No. RR-4:1-11
13. 13. CDC (1995) USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 44, No. RR-8:5-34
14. 14. CDC (1996) Coccidiodomycosis in Arizona, 1990-1995. MMWR 45:1069-1073
15. 15. Coker RJ, Viviani M, Gazzard BG, Dupont B, Pohle HD, Murphy SM, et al (1993) Treatment of cryptococcosis with liposomal amphotericin B in 23 patients with AIDS. AIDS 7:829-835
16. 16. Como JA, Dismukes WE (1994) Oral azole drugs as systemic antifungal therapy. N Engl J Med 330:263-272
17. 17. Cunliffe NA, Denning DW (1995) Uncommon invasive mycoses in AIDS. AIDS 9:411-420
18. 18. De Beule K (1996) Itraconazole: pharmacology, clinical experience and future development. Int J Antimicrob Agents 6:175-181
19. 19. De Gans J, Portegies P, Tiessens G, et al (1992) Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 6:185-190
20. 20. De Lalla F, Pellizzer G, Vaglia A, et al (1995) Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. Clin Infect Dis 20:263-266
21. 21. Denning DW, Tucker RM, Hanson LH, et al (1989) Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 149:2301-2308
22. 22. Denning DW, Armstrong RW, Lewis BH, et al (1991) Elevated cerebrospinal fluid pressure in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 91:267-272
23. 23. Denning DW, Follansbee SE, Scolaro M, et al (1991) Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 324:654-662
24. 24. Dismukes WE (1993) Management of cryptococcosis. Clin Infect Dis 17 [Suppl 2]:507-512
25. 25. Domachowske JB (1996) Pediatric human immunodeficiency virus infection. Clin Microbiol Rev 4:448-468
26. 26. Elmets CA (1994) Management of common superficial fungal infections in patients with AIDS. J Am Acad Dermatol 31:60-63
27. 27. Fader RC, McGinnis MR (1988) Infections caused by dematiaceous fungi: chromoblastomycosis and phaeo-hyphomycosis. Infect Dis Clin North Am 2:925-938
28. 28. Flynn PM, Cunningham CK, Kerkering T, San Jorge AR, Peters VB, Pitel PA, Harris J, Gilbert G, Castagnaro L, Robinson P (1995) Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group. J Pediatr 127:322-328
29. 29. Fojtasek MF, Kleiman MB, Connolly-Stringfield P, Blair R, Wheat LJ (1994) The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children. Pediatr Infect Dis J 13:801-805
30. 30. Galgiani JA, Ampel NM (1990) Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis 162:1165-1169
31. 31. Galgiani JN, Catanzaro A, Cloud GA, Higgs J, Friedman BA, Larsen RA, Graybill JR (1993) Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group. Ann Intern Med 119:28-35
32. 32. Geisinger KR (1995) Endoscopic biopsies and cytologic brushings of the esophagus are diagnostically complementary. Am J Clin Pathol 103:295-299
33. 33. Goldani LZ, Sugar AM (1995) Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis 21:1275-1281
34. 34. Golden SE, Morgan CM, Bartley DL, et al (1986) Disseminated coccidioidomycosis with chorioretinitis in early infancy. Pediatr Infect Dis J 5:272-274
35. 35. Gonzalez C, Shetty D, Lewis L, Mueller B, Pizzo PA, Walsh TJ (1996) Cryptococcosis in HIV-infected children. Pediatr Infect Dis J 15:796-800
36. 36. Gonzalez CE, Venzon D, Mueller BU, Pizzo PA, Walsh TJ (1996) Risk factors for fungemia in children infected with the human immunodeficiency virus: a case control study. Clin Infect Dis 23:515-521
37. 37. Groll AH, Walsh TJ (1997) Antifungal triazoles. In: Yu VL, V Merigan TC, Barriere S, White NJ (eds) Antimicrobial chemotherapy. Williams and Wilkins, Baltimore MD:1158-70
38. 38. Groll AH, Beeg T, Ehrenberg A, Kreuz WD, Kornhuber B (1994) Pneumocystis carinii pneumonia despite aerosolized pentamidine chemoprophylaxis (English abstract). Monatsschr Kinderheilkd 142:491-494
39. 39. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K (1996) Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 33:23-32
40. 40. Grubman S, Simonds RJ (1996) Preventing Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children: new guidelines for prophylaxis. Pediatr Infect Dis J 15:165-168
41. 41. Mass A, Hyatt AC, Kattan M, et al (1987) Hoarseness in immunocompromised children: association with invasive fungal infection. J Pediatr 111:731-733
42. 42. Heller HM, Fuhrer J (1991) Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS 5:1243-1246
43. 43. Hiemenz JW, Walsh TJ (1996) Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 22 [Suppl 2]:133-144
44. 44. Hood S, Denning DW (1996) Treatment of fungal infections in AIDS. J Antimicrob Chemother 37 [Suppl B]:71-85
45. 45. Hughes WT (1995) Pneumocystis in infants and children (letter). N Engl J Med 333:320-321
46. 46. Ieven M, Goossens H (1997) Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev 10:242-256
47. 47. Jeffrey MA, Beard JS, Benson PM, Skillman L (1993) Rapid diagnosis of coccidioidomycosis with a DNA probe to ribosomal RNA. Arch Dermatol 129:1589-1593
48. 48. Judson MA, Sahn SA (1994) Endobronchial lesions in HIV-infected individuals. Chest 105:1314-1323
49. 49. Keating JJ, Rogers T, Petrou M, Cartledge JD, Woodrow D, Nelson M, Hawkins DA, Gazzard BG (1994) Management of pulmonary aspergillosis in AIDS: an emerging clinical problem. J Clin Pathol 47:805-809
50. 50. Khoo SH, Denning DW (1994) Invasive aspergillosis in patients with AIDS. Clin Infect Dis 19 [Suppl 1]:41-48
51. 51. Klotz S (1989) Malassezia furfur. Infect Dis Clin North Am 3:53-64
52. 52. Larsen RA, Leal MAE, Chan LS (1990) Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med 113:183-187
53. 53. Larsen RA, Bozzette SA, Jones BE, et al (1994) Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 19:741-745
54. 54. Lee JW, Seibel NL, Amantea M, Whitcomb P, Pizzo PA, Walsh TJ (1992) Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. J Pediatr 120:987-993
55. 55. Leenders AC, Reiss P, Portegies P, Clezy K, Hop WC, Hoy J, et al (1997) Liposomal amphotericin B (AmBisome) compared with amphotericin B followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 11:1463-1471
56. 56. Leggiadro RJ, Barrett FF, Hughes WT (1988) Disseminated histoplasmosis of infancy. Pediatr Infect Dis J 7:799-805
57. 57. Leggiadro R, Kline M, Hughes W (1991) Extrapulmonary cryptococcosis in children with AIDS. Pediatr Infect Dis J 10:658-662
58. 58. Leibovitz E, Rigaud M, Pollack H, Lawrence R, Chandwani S, Krasinski K, Borkowsky W (1990) Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T-lymphocytes per cubic millimeter. N Engl J Med 323:531-533
59. 59. Leibovitz E, Rigaud M, Chandwani S, et al (1991) Disseminated fungal infection in children with human immunodeficiency virus. Pediatr Infect Dis J 10:888-894
60. 60. LoBuglio K, Taylor JW (1995) Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei. J Clin Microbiol 33:85-89
61. 61. Lortholary O, Meyonas MC, Dupont B, Cadranel J, Salmon-Ceron D, Peyramond D, Simonin D (1993) Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. Am J Med 95:177-187
62. 62. MacDonald N, Steinhoff MC, Powell KR (1981) Review of coccidioidomycosis in immunocompromised children. Am J Dis Child 135:553-556
63. 63. Manfredi R, Mastroianni A, Coronado OV, Chiodo F (1997) Fluconazole as prophylaxis against fungal infection in pateints with advanced HIV infection. Arch Intern Med 157:64-69
64. 64. Menichetti F, Fiorio M, Tosti A, et al (1996) High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis 22:838-840
65. 65. Merz W, Karp J, Hoagland M (1988) Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis 158:1046-1055
66. 66. Meyer RD (1994) Treatment of fungal infections in patients with HIV-infection or AIDS. Zentralbl Bakteriol 281:1-7
67. 67. Minamoto GY, Rosenberg AS (1997) Fungal infections in patients with acquired immunodeficiency syndrome. Med Clin North Am 81:381-409
68. 68. Mitchell TG, Freedman EZ, White TJ, Taylor JW (1994) Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans. J Clin Microbiol 32:253-255
69. 69. Nagy-Agren SE, Chu P, Walker Smith GJ, Waskin HA, Altice FL (1995) Zygomycosis (Mucormycosis) and HIV infection: report of three cases and review. J Acquir Immune Defic Syndr Hum Retrovirol 10:441-449
70. 70. Pappas PG, Pottage JC, Powderly WG, Fraser VJ, Stratton CW, McKenzie S, Tapper ML, Chmel H, Bonebrake FC, Blum R, et al (1992) Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 116:847-853
71. 71. Perfect JR (1989) Cryptococcosis. Infect Dis Clin North Am 3:77-102
72. 72. Perfect JR, Schell WA, Rinaldi MG (1993) Uncommon invasive fungal pathogens in the acquired immunodeficiency syndrome. J Med Vet Mycol 31:175-179
73. 73. Pillay T, Pillay DG, Bramdev A (1997) Disseminated histoplasmosis in a human immunodeficiency virus-infected African child. Pediatr Infect Dis J 16:417-418
74. 74. Piscitelli SC, Flexner C, Minor JR, Polis MA, Masur H (1996) Drug interactions in patients infected with human immunodeficiency virus. Clin Infect Dis 23:685-693
75. 75. Powderly WG (1993) Cryptococcal meningitis and AIDS. Clin Infect Dis 17:837-842
76. 76. Powderly WG, Saag MS, Cloud GA, et al (1992) A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 326:793-798
77. 77. Powderly WG, Cloud GA, Dismukes WE, Saag MS (1994) Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 18:789-792
78. 78. Powderly WG, Finkelstein D, Feinberg J, et al (1995) A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced HIV infection. N Engl J Med 332:700-705
79. 79. Prariyachatigul C, Chaiprasert A, Meevootisom V, Pattanakitsakul S (1996) Assessment of a PCR technique for the detection and identification of Cryptococcus neoformans. J Med Vet Mycol 34:251-258
80. 80. Redline R, Redline S, Boxerbaum B, et al (1985) Systemic Malassezia furfur infections in patients receiving intralipid therapy. Hum Pathol 16:815
81. 81. Rex JH, Rinaldi MG, Pfaller MA (1995) Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39:1-8
82. 82. Rinaldi MG (1996) Phaeohyphomycosis. Dermatol Clin 14:147-153
83. 83. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ (1993) Defective antifungal activity of monocyte-derived macrophages from HIV-infected children against Aspergillus fumigatus. J Infect Dis 168:1562-1565
84. 84. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ (1993) Impairment of neutrophil antifungal acticvity against hyphae from Aspergillus fumigatus in children infected with human imunodeficiency virus. J Infect Dis 167:905-911
85. 85. Saag MS, Powderly WG, Cloud GA, et al (1992) Comparison of amphotericin B with fluconazole in the treatment of acute AIDS associated cryptococcal meningitis. N Engl J Med 326:83-89
86. 86. Schutze GE, Tucker NC, Jacobs RF (1992) Histoplasmosis and perinatal human immunodeficiency virus (letter). Pediatr Infect Dis J 11:501-502
87. 87. Sharkey PK, Graybill JR, Rinaldi MG, et al (1990) Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 23:577-586
88. 88. Sharkey PK, Graybill JR, Johnson ES, et al (1996) Amphotericin B lipid complex compared with amphoteriin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 22:315-321
89. 89. Shetty D, Giri N, Gonzalez CE, Pizzo, PA, Walsh TJ (1997) Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 16:216-221
90. 90. Simonds RJ, Lindegren ML, Thomas P, et al (1995) Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired HIV infection in the United States. N Engl J Med 332:786-790
91. 3: demonstration of efficacy in a positive, multicenter trial. Clin Infect Dis 23:1282-1286
92. 92. Sirisanthana V, Sirisanthana T (1995) Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. Pediatr Infect Dis J 14:935-940
93. 93. Supparatpinyo K, Khamwan C, Baosoung V, Nelson K, Sirisanthana T (1994) Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 344:110-113
94. 94. Tanaka KI, Miyazaki T, Maesaki S, Mitsutake K, Kakeya H, Yamamoto Y, Yanagihara K, Hossain MA, Tashiro T, Kohno S (1996) Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis. J Clin Microbiol 34:2826-2828
95. 95. Teh W, Matti BS, Marisiddaiah H, Minamoto GY (1995) Aspergillus sinusitis in patients with AIDS: report of three cases and review. Clin Infect Dis 21:529-535
96. 96. Tobón AM, Franco L, Espinal D, Gómez I, Arango M, Phdsci MA, Trujillo H, Restrepo A (1996) Disseminated histoplasmosis in children: the role of itraconazole therapy. Pediatr Infect Dis J 15:1002-1008
97. 97. Tumbarello M, Ventura G, Caldarola G, Morace G, Cauda R, Ortona L (1993) An emerging opportunistic infection in HIV patients: a retrospective analysis of 11 cases of pulmonary aspergillosis. Eur J Epidemiol 9:638-644
98. 98. Van den Saffele JK, Boelaert JR (1996) Zygomycosis in HIV-positive patients: a review of the literature. Mycoses 39:77-84
99. 99. Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al (1997) Treatment of cryptococcal meningitis associated with the acquired immuno-deficiency syndrome. New Engl J Med 337:15-21
100. 100. Walsh TJ, Gray W (1987) Candida epiglottitis in immunocompromised patients. Chest 91:482-485
101. 101. Walsh TJ, Pizzo PA (1992) Laboratory diagnosis of candidiasis. In: Bodey GP (ed) Candidiasis, 2nd edn. Raven Press, New York, NY 109-136
102. 102. Walsh TJ, Gonzalez C, Roilides E, et al (1995) Fungemia in children infected with the human immunodeficiency virus: new epidemiological patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin Infect Dis 20(4):900-906
103. 103. Walsh TJ, Gonzalez C, Lyman CA, Chanock SJ, Pizzo PA (1996) Invasive fungal infections in children: Recent advances in diagnosis and treatment. Adv Ped Infect Dis 11:187-290
104. 104. Walsh TJ, Hiemenz JW, Anaissie E (1996) Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect Dis Clin North Am 10:365-400
105. 105. Walsmley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L (1993) Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 12:673-682
106. 106. Wheat LJ, Connolly-Springfield PA, Baker RL, et al (1990) Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis, and treatment, and review of the literature. Medicine 69:361-364
107. 107. Wheat J, Hafner R, Wulfsohn M, et al (1993) Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med Apr 118:610-616
108. 108. Wheat J, Hafner R, Korzun AH, Limjoco MT, Spencer P, Larsen RA, Hecht FM, Powderly W (1995) Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med 98:336-342
109. 109. Wright M, Firkin S, Haller JO (1993) Aspergillosis in children with acquired immunodeficiency. Pediatr Radiol 23:492-494
110. 110. Wrzolek MA, Brudkowska J, Kozlowski PB, Rao C, Anzil AP, Klein EA, Del Rosario C, Abdu A, Kaufman L, Chandler FW (1995) Opportunistic infections of the central nervous system in children with HIV-infection: report of 9 autopsy cases and review of literature. Clin Neuropathol 14:187-196
111. 111. Zahraa J, Herold B, Abrahams C, Johnson D (1996) Bronchiolitis obliterans organizing pneumonia in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 15:448-451